Engineering liver
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Interest in “engineering liver” arises from multiple communities: therapeutic replacement; mechanistic models of human processes; and drug safety and efficacy studies. An explosion of micro- and nanofabrication, biomaterials, microfluidic, and other technologies potentially affords unprecedented opportunity to create microphysiological models of the human liver, but engineering design principles for how to deploy these tools effectively toward specific applications, including how to define the essential constraints of any given application (available sources of cells, acceptable cost, and user-friendliness), are still emerging. Arguably less appreciated is the parallel growth in computational systems biology approaches toward these same problems—particularly in parsing complex disease processes from clinical material, building models of response networks, and in how to interpret the growing compendium of data on drug efficacy and toxicology in patient populations. Here, we provide insight into how the complementary paths of engineering liver—experimental and computational—are beginning to interplay toward greater illumination of human disease states and technologies for drug development. (Hepatology 2014;60:1426–1434)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vascularized and functional human liver from an iPSC-derived organ bud transplant
Takebe, T., Sekine, K., Enomura, M., Koike, H., Kimura, M., Ogaeri, T., Zhang, R.-R., Ueno, Y., Zheng, Y.-W., Koike, N., et al. (2013) · Nature · doi:10.1038/nature12271 · Cited by 2,170 · cited 1×
“Encouragingly, spontaneous formation of vascularized “liver bud” structures have been observed when human iPSC-derived hepatic-specified cells (immature endomermal cells destined to track to the hepatic cell fate) are combined in vitro with human umbilical vein ECs, and these structures form patent vascularized vessel…”
Data-driven prediction of drug effects and interactions
Tatonetti, N. P., Ye, P. P., Daneshjou, R., & Altman, R. B. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003377 · Cited by 936 · cited 2×
“A powerful new approach for analyzing postmarket surveillance data to account for sparse information and covariation of factors in large clinical trials that permits the identification of drug targets, prediction of drug indications, and discovery of drug-class interactions may allow further inroads in understanding D…”
Organotypic liver culture models: meeting current challenges in toxicity testing
LeCluyse, E. L., Witek, R. P., Andersen, M. E., & Powers, M. J. (2012) · Critical Reviews in Toxicology · doi:10.3109/10408444.2012.682115 · Cited by 363
Hepatic stellate cells require a stiff environment for myofibroblastic differentiation
Olsen, A. L., Bloomer, S. A., Chan, E. P., Gaça, M. D. A., Georges, P. C., Sackey, B., Uemura, M., Janmey, P. A., & Wells, R. G. (2011) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00412.2010 · Cited by 355
Geometric control of vascular networks to enhance engineered tissue integration and function
Baranski, J. D., Chaturvedi, R. R., Stevens, K. R., Eyckmans, J., Carvalho, B., Solorzano, R. D., Yang, M. T., Miller, J. S., Bhatia, S. N., & Chen, C. S. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1217796110 · Cited by 267 · cited 1×
“A path to accomplishing the fine scale has recently been applied to creating microscale perfused vascular liver structures by extrusion of arrays of molten sugar cylinders, which can subsequently be infused with gel suspensions containing cells, dissolving the sugar to yield perfusable channels that can be lined with…”
Yamada, M., Utoh, R., Ohashi, K., Tatsumi, K., Yamato, M., Okano, T., & Seki, M. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.07.068 · Cited by 247
Khan, A. A., Shaik, M. V., Parveen, N., Rajendraprasad, A., Aleem, M. A., Aejaz, M., Srinivas, G., Avinash, T., Tiwari, S. K., Kumaresan, K., et al. (2010) · Cell Transplantation · doi:10.3727/096368910x498241 · Cited by 183
The role of ECM proteins and protein fragments in guiding cell behavior in regenerative medicine
Barker, T. H. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.02.027 · Cited by 181
Cited by
3D bioprinting of tissues and organs for regenerative medicine
Vijayavenkataraman, S., Yan, W.-C., Lu, W. F., Wang, C.-H., & Fuh, J. Y. H. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.07.004 · Cited by 630
Bohn, T., McDougall, G. J., Alegría, A., Alminger, M., Arrigoni, E., Aura, A., Brito, C., Cilla, A., El, S. N., Karakaya, S., et al. (2015) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201400745 · Cited by 265
Ma, C., Zhao, L., Zhou, E.-M., Xu, J., Shen, S., & Wang, J. (2016) · Analytical Chemistry · doi:10.1021/acs.analchem.5b03869 · Cited by 145
Complex bile duct network formation within liver decellularized extracellular matrix hydrogels
Lewis, P. L., Su, J., Yan, M., Meng, F., Glaser, S. S., Alpini, G. D., Green, R. M., Sosa-Pineda, B., & Shah, R. N. (2018) · Scientific Reports · doi:10.1038/s41598-018-30433-6 · Cited by 68
Directing the growth and alignment of biliary epithelium within extracellular matrix hydrogels
Lewis, P. L., Yan, M., Su, J., & Shah, R. N. (2019) · Acta Biomaterialia · doi:10.1016/j.actbio.2018.12.039 · Cited by 61
Metadata
- Authors
- Griffith, L. G., Wells, A., & Stolz, D. B.
- Venue
- Hepatology
- Published
- 2014-10
- Volume
- 60
- Issue
- 4
- Pages
- 1426-1434
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W3187749979
- Cited by
- 52
- References
- 8
- FWCI
- 4.14
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.